Albuterol sulfate is the active ingredient behind the most common rescue inhaler in the United States, sold under the brand names ProAir HFA, Ventolin HFA, and Proventil HFA, plus the breath-activated ProAir RespiClick and ProAir Digihaler. It is a short-acting beta-2 agonist (SABA) that relaxes airway muscles within minutes, making it the standard quick-relief treatment for asthma and chronic obstructive pulmonary disease (COPD) flare-ups. Albuterol has been sold as a generic since the 1980s in older CFC formulations, and AB-rated generic HFA versions of all three major brands have been FDA-approved since 2020, which is unusually late for such an old molecule because of a patent dispute over the HFA propellant delivery system rather than the drug itself.
Pharmacy cash prices for albuterol in 2026 vary more than most people expect for a decades-old generic drug. Generic albuterol HFA inhalers run $25 to $60 at most chains, while the brand-name ProAir HFA, Ventolin HFA, and Proventil HFA versions cost $50 to $100 without insurance. Where you fill the prescription matters as much as which brand your doctor writes: Kroger and Walmart consistently post the lowest cash prices, while Costco's cash price for this particular drug runs higher than most competitors. Patients managing Medicaid income limits or comparing plans during Medicare eligibility season should know that generic albuterol is one of the cheapest maintenance prescriptions on nearly every formulary, unlike specialty inhalers such as Trelegy Ellipta or biologics like Dupixent.
Medicare and the Inflation Reduction Act reshaped prescription costs broadly in 2026, but albuterol sits outside most of that story because it is already a cheap generic. Albuterol was not one of the drugs selected for Medicare's first two rounds of price negotiation, so it has no negotiated Maximum Fair Price the way Eliquis or Jardiance does. Instead, albuterol benefits from the same $2,100 annual Part D out-of-pocket cap that applies to every covered drug, and its low generic-tier copay rarely comes close to that ceiling on its own. The bigger cost risk for albuterol is not the pharmacy counter, it is the emergency room, where a single nebulizer treatment can be billed at facility rates many times the retail inhaler price.
What Albuterol Costs by Point of Pay (2026)
The price you pay depends almost entirely on WHERE you pay. The same albuterol can cost many times more at a hospital than at your local pharmacy:
2026 Albuterol Price by Point of Pay| Where you pay | Typical cost | Notes |
|---|
| Pharmacy counter (retail, cash) | $25 - $100/inhaler | Generic HFA runs $25-$60 in 2026; brand-name ProAir/Ventolin/Proventil runs $50-$100. |
| Medicare Part D (2026) | $0 - $15/month (generic); up to $47/month (brand) | Generic albuterol sits on formulary tier 1 on nearly every 2026 Part D plan; prior authorization is rarely needed. |
| Commercial insurance | $5 - $30 (generic); $30 - $60 (brand, after PA if required) | Some plans require step therapy or a generic-substitution attempt before covering the brand inhaler. |
| Manufacturer coupon or savings card | As low as $10 - $35/inhaler | Teva's ProAir savings card and GSK's Ventolin HFA offer cap the price for commercially-insured or uninsured cash-paying patients. |
| Medicaid | $1 - $4/prescription | Generic albuterol is on the preferred drug list in nearly every state Medicaid formulary; the nominal copay varies by state. |
Cash prices reflect 2026 GoodRx and chain pharmacy survey data. Part D and commercial copays depend on your plan's formulary tier and whether the pharmacy dispensed brand or generic.
Source: CMS Medicare Part D 2026 benefit design, GoodRx, Teva/GSK/Merck savings program pages
Why Hospitals Charge So Much
Emergency departments and inpatient units almost never bill albuterol as a standalone $30 inhaler. Instead, a nebulizer breathing treatment gets bundled into a facility charge that covers the drug, the disposable nebulizer kit, respiratory therapist time, and general overhead, and that bundled charge commonly lands between $200 and $900 per treatment on an itemized bill. A patient who receives three nebulizer treatments during a single ER visit for an asthma attack can see $600 to $2,700 in albuterol-related line items even though the wholesale drug cost for all three treatments is well under $5.
Two HCPCS codes explain most of the confusion on these bills. J7613 covers FDA-approved, non-compounded albuterol nebulizer solution billed per 1 mg unit dose, and the 2026 Medicare Part B average sales price for that code is about $0.076 per mg, meaning the drug itself is nearly free; the facility markup is what drives the total. J7620 covers a combination albuterol-ipratropium nebulizer solution used for COPD flares. If a bill shows several hundred dollars against either code, request the itemized charge master entry and compare it to the Medicare Part B allowed amount, since Medicare and most commercial plans will only reimburse the outpatient facility rate and will not pay unexplained markups above it.
HCPCS J-Codes: What Appears on Your Bill
Most patients use albuterol as a self-administered HFA metered-dose inhaler, which Medicare covers under Part D with no HCPCS J-code involved. But when albuterol is delivered as a liquid nebulizer solution through a home nebulizer machine classified as durable medical equipment (DME), Medicare bills it under Part B using the codes below, a billing quirk similar to how insulin pump supplies are billed differently from insulin pens.
HCPCS J-codes for Albuterol| Code | Description | What to look for |
|---|
| J7613 | Albuterol, inhalation solution, FDA-approved final product, non-compounded, administered through DME, unit dose, per 1 mg | Confirm the units billed match your actual nebulizer vial dose (commonly 2.5 mg per vial = 2.5 units); watch for duplicate billing across multiple daily treatments. |
| J7620 | Albuterol, up to 2.5 mg, and ipratropium bromide, up to 0.5 mg, FDA-approved final product, non-compounded, administered through DME | This combination code should only appear if your prescriber ordered the combo drug (brand name DuoNeb) for COPD, not for straight asthma rescue treatment. |
DME nebulizer supplies, including albuterol solution, require the Part B deductible ($283 in 2026) and 20% coinsurance, unlike the flat generic copay you pay for an HFA inhaler under Part D.
Source: CMS HCPCS Level II code set; DME MAC fee schedules
Patient Assistance Programs
Because generic albuterol is already inexpensive, most assistance programs for this drug target patients who specifically need a brand-name inhaler (allergy to a generic's inactive ingredients, a device feature like ProAir RespiClick's breath-activation, or a formulary that only covers the brand). If you have no insurance at all, a patient assistance program can get any of the three major brands free or nearly free.
Patient assistance programs for Albuterol| Manufacturer program | Cost / Benefit | How to apply |
|---|
| Teva Cares Foundation Patient Assistance Program (ProAir) | Free ProAir HFA or ProAir RespiClick for uninsured US residents at or below 300% FPL | tevacares.org |
| GSK Ventolin HFA Savings Offer | No more than $35 per inhaler for eligible commercially-insured or uninsured patients (up to 12 uses) | gskforyou.com |
| Merck Patient Assistance Program (Proventil HFA) | Free Proventil HFA for uninsured US residents who meet income guidelines | merckhelps.com |
| NeedyMeds Drug Discount Card | Variable discount on brand or generic albuterol, accepted at most US pharmacies | needymeds.org |
Manufacturer copay cards and coupons, including the GSK Ventolin offer and Teva's ProAir savings card, cannot be used by anyone enrolled in Medicare, Medicaid, TRICARE, or VA benefits under the federal anti-kickback statute (42 U.S.C. section 1320a-7b). Government-insured patients who need brand-name help should apply directly to the manufacturer's income-based patient assistance program instead.
Source: Teva Cares Foundation, GSK For You, Merck Patient Assistance Program, NeedyMeds.org
Medicare Part D
Medicare Part D classifies generic albuterol HFA inhalers as tier-1 generic drugs on nearly every 2026 plan formulary, which typically means a $0 to $15 copay per inhaler and no prior authorization requirement. Brand-name ProAir HFA, Ventolin HFA, or Proventil HFA can land on a higher formulary tier if your plan prefers the generic, sometimes pushing the copay to $30 or more; ask your plan to run a formulary exception if your prescriber documents a medical reason you need the specific brand.
Nebulizer solution delivered through a home nebulizer machine falls under Medicare Part B, not Part D, because the nebulizer itself is classified as durable medical equipment. That means the Part B deductible ($283 in 2026) and 20% coinsurance apply to nebulizer albuterol, while the flat generic copay applies to the HFA inhaler form. Patients who use both a rescue inhaler and a home nebulizer should expect two different billing pathways on the same drug.
Because albuterol's Part D copay is already low, most patients never approach the $2,100 annual Part D out-of-pocket cap from albuterol alone. The cap matters more for patients also taking higher-cost respiratory drugs like Trelegy Ellipta, Breo Ellipta, or biologics such as Dupixent for severe asthma; once total Part D spending across all covered drugs hits $2,100 in 2026, every covered drug, including albuterol, becomes $0 for the rest of the calendar year.
Common Albuterol Billing Errors
If your albuterol bill looks unusually high, whether at the pharmacy or after an ER visit, check for these common issues before paying:
- ER nebulizer treatments bundled into a separate high-cost 'aerosol therapy' or 'respiratory therapy' line item ($200-$900) on top of the drug charge itself, sometimes duplicated for each individual treatment during the same visit.
- Pharmacy dispensing brand-name ProAir, Ventolin, or Proventil and billing the higher brand copay when the prescription authorized substitution with the AB-rated generic.
- A DME supplier billing Medicare Part B under J7613 for nebulizer solution when the patient actually used a personal HFA inhaler at home, not a covered nebulizer machine.
- A refill filled early in the same 30-day window billed as a brand-new fill with a second full copay instead of a partial refill adjustment.
- An insurer applying a non-preferred or specialty-tier copay to generic albuterol when the plan's own formulary lists it as a tier-1 generic drug.
- Full Part B coinsurance charged on nebulizer solution before the 2026 Part B deductible of $283 had actually been met for the year.
Frequently Asked Questions
Is there a generic for albuterol inhalers?
Yes. Albuterol is already the generic name, and AB-rated generic HFA inhalers exist for all three major brands: Perrigo's generic matches ProAir HFA (FDA-approved 2020), Cipla's generic matches Ventolin HFA, and Sandoz sells an authorized generic of Proventil HFA. There is no biosimilar because albuterol is a small-molecule drug, not a biologic. Generic HFA inhalers typically cost 40-70% less than the matching brand in 2026.
How do I apply for the Teva Cares Foundation patient assistance program?
Visit tevacares.org or call 877-237-4881 to request the ProAir application. Your prescriber completes the physician section, and you submit proof of income, US residency, and lack of drug coverage. Household income must be at or below 300% of the 2026 federal poverty level; applicants under 150% FPL must first apply for and be denied Medicare's Extra Help program. Processing takes about 2-3 weeks, and approved patients get free ProAir with annual renewal.
Can I use the ProAir or Ventolin savings card with Medicare?
No. Federal anti-kickback law bars manufacturer copay cards, including Teva's ProAir savings card and GSK's Ventolin HFA offer, from being used by anyone on Medicare, Medicaid, TRICARE, or VA benefits. Medicare beneficiaries who need help with a brand-name inhaler should apply to Teva Cares Foundation, GSK's income-based patient assistance program, or the Merck Patient Assistance Program instead.
What if my insurance denies coverage for a brand-name albuterol inhaler?
Request the written denial, then file a formal appeal with a letter of medical necessity from your prescriber within your plan's deadline. If the plan requires step therapy with the generic first, ask for a step-therapy override citing a documented allergy or inhaler-technique issue. If appeals fail, apply to the manufacturer's patient assistance program, or ask your prescriber to switch you to the AB-rated generic, which is covered on nearly every formulary.
Does the IRA negotiated Medicare price apply to albuterol?
No. Albuterol was not selected for either of Medicare's first two rounds of Inflation Reduction Act price negotiation, so it has no Maximum Fair Price the way Eliquis, Jardiance, or Xarelto do. Albuterol still benefits indirectly from the IRA through the general 2026 Medicare Part D annual out-of-pocket cap of $2,100, which applies across all your covered Part D drugs combined.
What does an albuterol inhaler cost without insurance in 2026?
A generic albuterol HFA inhaler costs $25 to $60 cash in most places in 2026, with Kroger Rx Savings Club around $28.70 and Walmart around $31.03 among the lowest chain prices. Brand-name ProAir HFA, Ventolin HFA, or Proventil HFA runs $50 to $100 without insurance. A free GoodRx coupon at CVS or Walgreens commonly brings the generic down to $15-$25.
Do I qualify for the Teva Cares Foundation patient assistance program?
You likely qualify if you are a US resident with a valid ProAir prescription, have no insurance coverage for the drug, and your household income is at or below 300% of the 2026 federal poverty level, which is $47,880 for one person or $99,000 for a household of four. If your income is under 150% FPL, you must first apply for and be denied Medicare's Low-Income Subsidy program before Teva Cares will approve your application.
What is the difference between ProAir HFA, Ventolin HFA, and Proventil HFA?
All three are brand-name albuterol sulfate HFA metered-dose inhalers with the same active ingredient and nearly identical clinical effect; they differ mainly in manufacturer (Teva, GSK, and Sandoz/Kindeva respectively), inactive ingredients, and inhaler device feel. ProAir also comes in a breath-activated version, ProAir RespiClick, and a dose-counting digital version, ProAir Digihaler, which some patients with coordination difficulty find easier to use correctly than a standard press-and-breathe HFA inhaler.
